Abstract
Extending the valproate registry to cover all antiepileptic drugs will be “prioritised in the next phase of [its] development”, the Department of Health and Social Care (DHSC) has said. The move follows recommendations in the Independent Medicines and Medical Devices Safety Review (IMMDSR), published in July 2020, in which the chair, Baroness Cumberlege, said that […]
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
